title: Dyslipidemia: blockbuster therapies are on the horizon.
abstract: Potential blockbuster therapies, such as proprotein convertase subtilisin/kexin type 9 inhibitors, are expected to revolutionize dyslipidemia treatment and raise global sales.
authors.forename: Rinki
authors.initials: R
authors.lastname: Patel
authors.forename: Kunj
authors.initials: K
authors.lastname: Gohil